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Abstract
The eukaryotic translation initiation factor 4E (eIF4E) is frequently overexpressed in human cancers and is associated
with cellular transformation, tumorigenesis, and metastatic progression. It is known that Mnks can phosphorylate
eIF4E. Protein phosphatase 2A (PP2A) functions as a tumor suppressor, and it was previously suggested to regulate
eIF4E phosphorylation. However, how PP2A regulates eIF4E phosphorylation has not been fully addressed. In this
study, we have not only validated the role of PP2A in regulation of eIF4E phosphorylation but also demonstrated the
mechanism underlying this process. Inhibition of PP2A using either okadaic acid or PP2A small interfering RNA (siRNA)
increased eIF4E phosphorylation, which could be abolished by the presence of the Mnk inhibitor CGP57380 or defi-
ciency of Mnk genes. Thus, Mnks are involved in PP2A-mediated regulation of eIF4E phosphorylation. Moreover, a de-
phosphorylation assay revealed that PP2A could directly dephosphorylate Mnk1 and eIF4E. m7GTP pull-down assay
detected more eIF4G and phospho-eIF4E and less 4EBP-1 in PP2A siRNA-transfected cells than in control siRNA-
transfected cells, indicating an increased cap binding of eIF4F complex. Accordingly, okadaic acid treatment or PP2A
knockdown increased the levels of c-Myc and Mcl-1, which are proteins known to be regulated by a cap-dependent
translation mechanism. Taken together, we conclude that PP2A negatively regulates eIF4E phosphorylation and eIF4F
complex assembly through dephosphorylation of Mnk and eIF4E, thus suggesting a novel mechanism by which PP2A
exerts its tumor-suppressive function.
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Introduction
Protein translational control is an important strategy by which eukaryotic
cells regulate gene expression. A prime target of translational control is
eukaryotic translation initiation factor 4E (eIF4E), which recognizes
and binds to the 7-methylguanosine cap structure present at the 5′ un-
translated regions of cellular mRNA and delivers these mRNA to the
eIF4F translation initiation complex. Assembly of the eIF4F complex
is dependent on eIF4E availability. Given that eIF4E is the least abun-
dant among the initiator factors involved in eIF4F complex, eIF4E is the
rate limiting factor for cap-dependent translation initiation [1]. Con-
sequently, changes in eIF4E levels profoundly affect translation rates of
certain proteins, particularly those related to cell growth and survival
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involved in oncogenesis (e.g., c-Myc, cyclin D1, hypoxia-inducible
factor 1, andMcl-1), which, under normal cellular conditions, are trans-
lationally repressed. eIF4E expression is frequently elevated in many
types of cancers and is associated with malignant progression. Inhibi-
tion of eIF4E effectively suppresses cellular transformation and tumor
growth, invasiveness, and metastasis [2–4].
eIF4E is regulated by phosphoinositide 3-kinase (PI3K)/mammalian
target of rapamycin and mitogen-activated protein kinase (MAPK)/
Mnk signaling and may act as a convergence point of these pathways.
The former enhances eIF4E activity through release from the 4E-BPs
[1,5,6], whereas the latter can increase eIF4E phosphorylation (usually
at Ser209) through Mnk1/2 [7]. The biologic significance of eIF4E
phosphorylation is not completely understood. However, it has been
suggested that phosphorylation of eIF4E may increase its affinity for
the cap of mRNA and may also favor its entry into initiation complexes
[6–8]. A recent study using genetically engineered mouse models has
clearly shown that Mnk-mediated eIF4E phosphorylation is absolutely
required for eIF4E’s oncogenic action [9].
Dynamic phosphorylation and dephosphorylation of proteins are
fundamental mechanisms used by cells to transduce signals. Protein phos-
phatase 2A (PP2A) is the major protein serine/threonine phosphatase
that modulates, particularly downregulates, activated protein kinases in
eukaryotic cells. PP2A controls the activities of some major protein
kinases involved in several important cell signaling pathways includ-
ing PI3K/Akt, Raf/MAPK/ERK kinase (MEK)/extracellular signal–
regulated kinase (ERK), and mammalian target of rapamycin/p70S6K
[10]. The core enzyme of PP2A comprises a 36-kDa catalytic subunit
(PP2Ac or C) that is always associated with a 65-kDa scaffolding subunit
(PR65 or A), which modulates its enzymatic properties, substrate
specificity, and subcellular localization [10].
PP2A is considered to be a tumor suppressor. Inhibition of PP2A
activity cooperates with other oncogenic changes to cause transforma-
tion of human cells [10–12]. However, the molecular mechanisms by
which PP2A exerts its tumor suppressive function have not been fully
elucidated. Whereas multiple pathways have been shown to be regu-
lated by PP2A in transformation [10,13], regulation of Mnk/eIF4E
signaling by PP2A has not been fully demonstrated except for previous
studies showing that the PP2A inhibitor okadaic acid (OA) increased
eIF4E phosphorylation [14–16]. In the current study, we investigated
the role of PP2A in regulation of eIF4E phosphorylation and eIF4F
assembly or activity and mechanisms underlying this process. We have
shown that PP2A negatively regulates eIF4E phosphorylation and
eIF4F assembly through dephosphorylating Mnk and eIF4E proteins.
Our findings thus suggest a novel mechanism by which PP2A sup-
presses transformation of human cells.
Materials and Methods
Reagents
OA, LY294002, and U0126 were purchased from LC laboratory
(Woburn, MA). SB203580 was purchased from Biomol (Plymouth
Meeting, PA). 4-Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d ]pyrimidine
(CGP57380) was purchased from Calbiochem (San Diego, CA). These
agents were dissolved in DMSO at a concentration of 20 mM, and
aliquots were stored at −80°C. Antibodies against phospho-Mnk1
(p-Mnk1; Thr197/202), eIF4G, eIF4E, 4EBP-1, phospho-4EBP-1
(p-4EBP-1; T37/46), phospho-eIF4E (p-eIF4E; Ser209), and Mcl-1
were purchased from Cell Signaling Technology, Inc (Beverly, MA).
Anti-PP2Ac antibody (clone 1D6) was purchased from Millipore/
Upstate (Billerica, MA). Mouse monoclonal anti–c-Myc antibody
was purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA).
Mouse monoclonal antiactin antibody was purchased from Sigma
Chemical Co. (St Louis, MO). Mouse and rabbit c-Myc tag antibodies
were purchased from Genscript (Piscataway, NJ) and Cell Signaling
Technology, Inc, respectively. 7-Methyl GTP (m7GTP)-sepharose 4B
was purchased from GE Healthcare Biosciences (Pittsburgh, PA).
Plasmids
pcDNA3-myc-Mnk1 [17] was kindly provided by Dr E. L. Martin
(Hospital Ramón y Cajal, Madrid, Spain). pcDNA-PP2Ac [18] was gen-
erously provided by Dr D. Pallas (Emory University, Atlanta, GA). To
make the flag-eIF4E expression construct, RT-PCR was used to amplify
the eIF4E coding region from total cellular RNA extracted from H157
cells using the following primers: forward 5′-GCAAGCTTATGGC-
GACTGTCGAACCGG-3′ and reverse 5′-GCGAATTCTTAAACAA-
CAAACCTATTTTTAG-3′. The final PCR product was then cloned
into p3×flag-Myc-CMV-26 expression vector from Sigma Chemical
Co. through HindIII and EcoRI cloning sites. The insert was confirmed
by DNA sequencing.
Cell Lines and Cell Culture
The human lung cancer cell lines used in this study were purchased
from the American Type Culture Collection (Manassas, VA). HEK293
cells were obtained from Dr K. Ye (Emory University). Wild type,
Mnk1 knockout (1KO), Mnk2 knockout (2KO), and Mnk1/Mnk2
double-knockout (DKO) murine embryonic fibroblasts were described
previously [19,20]. These cell lines were grown in monolayer culture
in RPMI 1640 medium or Dulbecco’s modified Eagle medium sup-
plemented with 5% fetal bovine serum at 37°C in a humidified atmo-
sphere consisting of 5% CO2 and 95% air.
Western Blot Analysis
Whole-cell protein lysates were prepared and analyzed by Western
blot analysis as described previously [21].
m7GTP Pull-down for Analysis of eIF4F Complex Formation
eIF4F complex in cell extracts was detected using affinity chroma-
tography m7GTP-sepharose as described previously [22].
Small Interfering RNA and Transfection
Human PP2Ac small interfering RNA (siRNA; sc-43509), which
consists of a pool of three target-specific 19 to 25 nt siRNA, was pur-
chased from Santa Cruz Biotechnology, Inc. The nonsilencing control
siRNA and transfection of the siRNA were described previously [21].
Immunoprecipitation and Dephosphorylation Assay
In 10-cm dishes, HEK293 cells were transiently transfected with
pcDNA3 or pcDNA3-myc-Mnk1 (for Mnk1 dephosphorylation) or
with pCMV-flag or pCMV-flag-eIF4E (for eIF4E dephosphorylation)
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Twenty-four hours
later, the cells were lysed in CHAPS lysis buffer containing 50mMTris-
HCl (pH7.5), 150 mMNaCl, 1 mM EDTA, 0.3% CHAPS, and pro-
tease inhibitors. For in vitro Mnk dephosphorylation assay, the clear
supernatant expressing myc-Mnk1 was split equally into two tubes: for
a PP2A sample, 1 μg of anti–myc-tag and 1 μg of anti-PP2Ac antibodies
were added; for a non-PP2A sample, 1 μg of anti–myc-tag and 1 μg of
mouse IgG antibodies were added. For the vector control sample, equal
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lysate and 1 μg of anti–myc-tag and 1 μg of mouse IgG were used. All
immunoprecipitation (IP) samples were mixed with 40 μl of protein G
bead and then incubated with constant shaking overnight at 4°C. After
IP, the beads were fully washed three times with the same lysis buffer and
cold 1× PBS and then washed twice with dephosphorylation assay buffer
containing 20 mM HEPES (pH 7.0), 0.1 mM DTT, 1 mM MnCl2,
0.1 mg/ml BSA, and protease inhibitors. The same procedure was used
for in vitro eIF4E dephosphorylation assay except for using anti–flag-tag
antibody to replace anti–myc-tag antibody in each aforementioned step.
The phosphatase reactions were carried out in the same dephosphoryla-
tion buffer for 16 hours at 30°C. Reactions were terminated by adding
SDS gel loading dye, and samples were run on 10% SDS-PAGE gels.
p-Mnk1 (T197/202) and p-eIF4E (S209) antibodies were used to detect
the phosphorylation levels of Mnk1 and eIF4E, respectively.
Results
PP2A Negatively Regulates eIF4E Phosphorylation
To determine whether PP2A regulates eIF4E phosphorylation,
we treated two lung cancer cell lines with the PP2A inhibitor OA at
100 nM, a concentration used to selectively inhibit PP2A activity in
the literature [23,24], for various times and then detected its effects
on eIF4E phosphorylation at Ser209. In these tested cell lines, OA
induced a time-dependent increase in p-eIF4E levels within the tested
time ranges (0-6 hours; Figure 1A). These results thus validate pre-
vious observations that OA inhibits eIF4E phosphorylation [14–16].
Moreover, we further confirmed our finding on OA-induced eIF4E
phosphorylation by inhibiting PP2A through specific knockdown of
PP2Ac with PP2Ac siRNA. As presented in Figure 1B, knockdown
of PP2Ac with either 5 or 20 nM PP2Ac siRNA substantially increased
p-eIF4E levels in both H157 and A549 cell lines. Collectively, these
data clearly indicate that inhibition of PP2A increases eIF4E phos-
phorylation. Furthermore, we expressed exogenous PP2Ac in HEK293
cells to determine whether enforced activation of PP2A inhibits eIF4E
phosphorylation. Indeed, we detected much less p-eIF4E in cells
transfected with PP2Ac than in cells transfected with empty vector
(Figure 1C ), demonstrating that overexpression of PP2Ac inhibits
eIF4E phosphorylaiton. Taking all data together, we conclude that
PP2A negatively regulates eIF4E phosphorylation.
PP2A Regulates eIF4E Phosphorylation through a
Mnk-Dependent Mechanism
It is well known that theMAPK-activated protein kinases Mnks, par-
ticularly Mnk1, regulate eIF4E activation through its phosphorylation
at serine 209 [8,19]. In our previously mentioned PP2A knockdown
experiment, p-Mnk1 (Thr197/202) levels were also increased in cells
in which PP2Ac was reduced (Figure 1B). In agreement, overexpres-
sion of PP2Ac also reduced the levels of p-Mnk1 (Figure 1C ). These
results suggest that Mnks might be involved in PP2A regulation of
eIF4E phosphorylation. Thus, we next determined whether Mnks are
Figure 1. Inhibition of PP2A with either OA (A) or PP2A siRNA (B) increases eIF4E phosphorylation, whereas overexpression of ectopic
PP2Ac (C) inhibits eIF4E phosphorylation. (A) The indicated cell lines were treated with 100 nM OA for the given times. (B) The indicated
cell lines were transfected with the given concentrations of control or PP2Ac siRNA for 48 hours. (C) HEK293 cells were transfected with
the given plasmids for 48 hours. After the aforementioned treatments, the cells were subjected to preparation of whole-cell protein
lysates and subsequent detection of the indicated proteins by Western blot analysis.
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involved in PP2A inhibition–induced eIF4E phosphorylation. To this
end, we first examined the effect of the presence of the Mnk inhibitor
CGP57380 on OA-induced eIF4E phosphorylation. The presence of
CGP57380 at concentrations ranging from 10 to 40 μM reduced basal
levels of p-eIF4E and blocked OA-induced increase in eIF4E phos-
phorylation in a concentration-dependent manner. CGP57380 at 20
or 40 μM almost abolished the ability of OA to increase p-eIF4E levels
(Figure 2A). Consistently, knockdown of PP2A with PP2Ac siRNA
increased p-eIF4E levels in the absence, but not in the presence, of
CGP57380 (Figure 2B). These data together indicate that Mnks are in-
volved in PP2A inhibition–induced increase in eIF4E phosphorylation.
Moreover, we determined the effects of OA on eIF4E phosphoryla-
tion in murine embryonic fibroblasts deficient in Mnk1 (1KO), Mnk2
(2KO), or both Mnk1 and Mnk2 (DKO). We noted that neither
knockout of Mnk1 (1KO) nor knockout of Mnk2 (2KO) alone elimi-
nated basal levels of p-eIF4E (although both did reduce basal levels
of p-eIF4E) or blocked OA-induced increase in eIF4E phosphoryla-
tion; however, the double knockout of both Mnk1 and Mnk2
(DKO) abolished not only basal levels of p-eIF4E but also OA-induced
eIF4E phosphorylation (Figure 2C ). These data suggest that both
Mnk1 and Mnk2 regulate eIF4E phosphorylation and are required
for mediating PP2A inhibition–induced eIF4E phosphorylation.
PP2A Regulates eIF4E Phosphorylation Independently of the
p38 MAPK Pathway
It has been shown that Mnks are regulated by ERK and p38 sig-
naling pathways [6], whereas PP2A regulates ERK and p38 activity
[10,25,26]. We therefore further investigated whether ERK and p38 are
involved in PP2A inhibition–induced eIF4E phosphorylation. The pres-
ence of the MEK inhibitor U0126 or the p38 inhibitor SB203580 alone
failed to block OA-induced increase in eIF4E phosphorylation in both
H157 and A549 cell lines (Figure 2D). In the experiment with PP2Ac
siRNA, the presence of U0126, but not SB203580, partially inhibited
knockdown of PP2A-induced increase in eIF4E phosphorylation. The
combination of U0126 and SB203580 had similar results to U0126
alone in affecting knockdown of PP2A-induced p-eIF4E increase (Fig-
ure 2B). Taken together, PP2A inhibition–induced eIF4E phosphoryla-
tion does not require activation of p38 signaling pathway. Although we
cannot rule out the possible role of the MEK/ERK signaling in this pro-
cess, it is unlikely that this signaling pathway plays a major role in me-
diating PP2A inhibition–induced eIF4E phosphorylation. In addition,
we looked at the effect of PI3K/Akt inhibition on OA-induced p-eIF4E
increase and found that the PI3K inhibitor LY294002 failed to block
OA-induced increase in eIF4E phosphorylation (Figure 2D), indicating
a mechanism independent of PI3K/Akt.
Figure 2. Inhibition of PP2A induces Mnk-dependent eIF4E phosphorylation (A-C) independent of ERK, p38, or PI3 kinase (B and D).
(A) H157 cells were pretreated with the indicated concentrations of CGP57380 for 30 minutes and then cotreated with 100 nM OA for
an additional 4 hours. (B) H157 cells were plated on six-well plates and, the next day, were transfected with 20 nM control (Ctrl) or PP2Ac
siRNA. After 20 hours, the cells were exposed to 20 μMof the indicated inhibitors for an additional 4 hours. (C) The indicated cell lines were
treated with 100 nMOA for 4 hours. (D) The indicated cell lines were pretreated with 20 μMU0126, SB203580, or LY294002 for 30 minutes
and then cotreated with 100 nMOA for an additional 4 hours. After the aforementioned treatments, the cells were harvested for preparation
of whole-cell protein lysates and subsequent Western blot analysis.
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PP2A Dephosphorylates Both Mnk and eIF4E
The aforementioned results led us to determine whether PP2A di-
rectly dephosphorylates Mnks and/or eIF4E. To this end, we con-
ducted a biochemical dephosphorylation assay. Specifically, we
transfected the target gene, Mnk1 or eIF4E, into HEK293 cells and
then co–pulled down the target protein with a tag antibody and en-
dogenous PP2A enzyme with PP2Ac-specific antibody for a subsequent
dephosphorylation assay using the immunoprecipitated human PP2A
as a source of PP2A enzyme. As presented in Figure 3A, p-Mnk1 levels
were much lower in cellular materials coimmunoprecipitated with anti-
Myc (i.e., for Myc-Mnk1) and anti-PP2Ac (for endogenous PP2A)
antibodies than those without the inclusion of anti-PP2Ac antibody,
indicating that PP2A functions as a Mnk phosphatase to directly de-
phosphorylate Mnk1. At the same time, we also determined whether
PP2A directly dephosphorylates eIF4E through the same approach.
As shown in Figure 3B, p-eIF4E levels were substantially reduced in
cellular materials coimmunoprecipitated with anti-flag (i.e., for flag-
eIF4E) and anti-PP2Ac antibodies compared with those without the
inclusion of anti-PP2Ac antibody, indicating that PP2A also functions
as an eIF4E phosphatase to directly dephosphorylate eIF4E. Thus,
these data indicate that PP2A negatively regulates eIF4E phosphoryla-
tion through direct dephosphorylation of both Mnk and eIF4E.
Inhibition of PP2A Enhances eIF4F Complex Assembly
The role of eIF4E phosphorylation in regulation of initiation com-
plex formation and cap-dependent translation is controversial [27],
although some studies have shown that phosphorylation of eIF4E in-
creases eIF4E’s affinity for the cap of mRNA and may also favor its
entry into initiation complexes [6–8]. Thus, we determined the effect
of PP2A inhibition on the formation of the initiation complex eIF4F.
To this end, we used m7GTP to pull down the eIF4F complex and then
analyzed the eIF4F assembly. As shown in Figure 4A, the amount of
eIF4G in the eIF4F complex was drastically increased in PP2Ac
siRNA-transfected cells compared with control siRNA-transfected cells.
Knockdown of PP2Ac increased p-eIF4E levels not only in whole cell
lysates but also in m7GTP–pulled down samples. These results clearly
indicate that inhibition of PP2A increases the association of eIF4E with
eIF4G, that is, increases eIF4F activity. To further demonstrate the ef-
fect of eIF4E phosphorylation on eIF4F assembly, we also determined
the effect of theMnk inhibitor CGP57380, which inhibits eIF4E phos-
phorylation, on eIF4F assembly. As presented in Figure 4B, CGP57380
caused substantial reduction of eIF4G in the eIF4F complex while
drastically inhibiting eIF4E phosphorylation. These data suggest that
induction of eIF4E phosphorylation (e.g., by PP2A knockdown) in-
deed increases eIF4F assembly or activity.
Inhibition of PP2A Decreases 4EBP-1 Interaction with eIF4E
To further demonstrate the effect of eIF4E phosphorylation on eIF4F
assembly, we determined whether inhibition of PP2A affects eIF4E and
4EBP-1 interaction given that 4EBP-1 is a key protein that binds to
eIF4E and restricts its availability to form eIF4F [28]. In the m7GTP
pull-down assay, we detected less 4EBP-1 in PP2Ac siRNA-transfected
cells than in control siRNA-transfected cells (Figure 4, C and D), in-
dicating that PP2A inhibition reduces the association of 4EBP-1 with
eIF4E. In the cells treated with CGP57380, we detected much more
4EBP-1 than in cells exposed to DMSO control (Figure 4D), suggesting
that inhibition of eIF4E phosphorylation may promote the association
of 4EBP-1 with eIF4E. Collectively, we suggest that PP2A inhibition
increases eIF4E phosphorylation, resulting in decreased association be-
tween 4EBP-1 and eIF4E.
Inhibition of PP2A Does Not Increase
4EBP-1 Phosphorylation
Moreover, we determined whether inhibition of PP2A increases
4EBP-1 phosphorylation, leading to increased eIF4F assembly. To this
end, we analyzed the effect of PP2A inhibition on 4EBP-1 phosphory-
lation. As presented in Figure 4E , knockdown of PP2A did not increase
p-4EBP-1 levels, whereas p-eIF4E levels were substantially elevated.
Therefore, it is clear that PP2A inhibition increases eIF4E phosphoryla-
tion without enhancing 4EBP-1 phosphorylation. In agreement, we also
looked at p-4EBP-1 levels in cells expressing ectopic PP2Ac and found
that p-4EBP-1 levels were not decreased compared with the control cells
(Figure 1C). These data again support the notion that PP2A negatively
regulates phosphorylation of eIF4E but not 4EBP-1.
eIF4E Phosphorylation in Part Contributes to PP2A
inhibition–Induced Mcl-1 and c-Myc Elevation
It has been recently shown that phosphorylated eIF4E promotes
tumorigenesis primarily by suppressing apoptosis, and accordingly,
the antiapoptotic protein Mcl-1 is one target of both p-eIF4E and
Mnk1 [9]. Thus, we further analyzed Mcl-1 levels in cells treated with
OA or transfected with PP2Ac siRNA. In both H157 and A549 cells,
knockdown of PP2Ac increased the levels of Mcl-1 (Figure 5A). More-
over, OA treatment also increased Mcl-1 levels (Figure 5B). These
results indicate that inhibition of PP2A elevates Mcl-1 levels. Further-
more, we determined whether eIF4E phosphorylation is involved in
this process by examining the effect of CGP57380 onMcl-1 expression
induced by PP2A inhibition. As presented in Figure 5C , the presence
Figure 3. PP2A dephosphorylates Mnk1 (A) and eIF4E (B). (A) Cell
lysates were prepared from HEK293 cells transfected with pcDNA3
or pcDNA3-myc-Mnk1 and followed by IP with anti-Myc tag plus
anti-IgG antibodies (without PP2A) or anti-Myc tag plus anti-PP2Ac
antibodies (with PP2A). (B) Cell lysates were prepared from
HEK293 cells transfected with pCMV-flag or pCMV-flag-eIF4E and
followed by IP with anti–flag-tag plus anti-IgG antibodies (without
PP2A) or anti–flag-tag plus anti-PP2Ac antibodies (with PP2A). After
the aforementioned procedures, the immunoprecipitates were
then subjected to in vitro dephosphorylation assay, in which the
endogenous PP2A was pulled down with anti-PP2Ac antibody as a
source of PP2A, as described in detail in Materials and Methods,
followed by Western blot analysis to detect p-Mnk1 (T197/202) (A)
and p-eIF4E (S209) (B), respectively.
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of CGP57380 blocked eIF4E phosphorylation, but only weakly or par-
tially inhibited OA-induced Mcl-1 elevation (approximately by 23%).
c-Myc is another protein known to be regulated by cap-dependent
translation [29] and PP2A [30,31]. Similar toMcl-1, both OA treatment
and transfection of PP2Ac siRNA increased c-Myc protein levels (Fig-
ure 6, A and B). The presence of CGP57380 substantially abrogated
OA-induced increase in c-Myc, albeit not completely, while abolishing
OA-induced eIF4E phosphorylation (Figure 6C). Thus, the data sug-
gest that eIF4E phosphorylation partly contributes to PP2A inhibition–
induced c-Myc elevation.
Discussion
In this study, we found that both treatment of cancer cells with the
small molecule PP2A inhibitor OA and transfection of cancer cells with
PP2Ac siRNA increased eIF4E phosphorylation at Ser209 (Figure 1, A
and B). Complementarily, overexpression of PP2Ac substantially de-
creased p-eIF4E levels (Figure 1C ). Collectively, our findings clearly
demonstrate that PP2A inhibits eIF4E phosphorylation.
Mnks, particularly Mnk1, are kinases known to phosphorylate
eIF4E at Ser209 [8,19]. In this study, we further showed that the pres-
ence of Mnk inhibitor CGP57380 and deficiency of both Mnk1 and
Mnk2 genes abolished eIF4E phosphorylation induced by OA or PP2Ac
siRNA (Figure 2). These results indicate that PP2A inhibition–induced
eIF4E phosphorylation is an Mnk-dependent event. We then addressed
the question of what the underlying mechanisms are. Through the de-
phosphorylation assay, we further showed that PP2A could directly de-
phosphorylate both Mnk1 and eIF4E (Figure 3), indicating that PP2A
functions as the phosphatase of Mnk1 and eIF4E. Thus, we conclude
that PP2A negatively regulates eIF4E phosphorylation through direct de-
phosphorylation of both Mnk1 and eIF4E. Our current findings not
only confirm previous observations that PP2A directly dephosphorylates
eIF4E in vitro [16] but also demonstrate the role of PP2A in direct de-
phosphorylation of Mnk1. To the best of our knowledge, PP2A de-
phosphorylation of Mnk1 has not been reported previously.
The effect of eIF4E phosphorylation on cap-dependent translation
initiation remains controversial [27]. Increased eIF4E phosphorylation
by OA-induced inhibition of PP2A was shown to have no effect on
eIF4E binding to the mRNA cap [15,16], whereas eIF4E phosphory-
lation was shown to be associated with increased protein translation
[14,32,33]. In our study, we found that siRNA-mediated knockdown
of PP2A increased the amount of eIF4G in the eIF4F complex pulled
down by the m7GTP (Figure 4A), indicating that PP2A inhibition
increases eIF4F assembly. Complementarily, inhibition of eIF4E with
CGP57380 decreased the amount of eIF4G in the eIF4F complex
(Figure 4B), indicating that eIF4E phosphorylation does affect eIF4F
Figure 4. Effect of inhibition of PP2A (A and C-E) or Mnk (B and D) on the assembly of eIF4E with eIF4G (A and B), 4EBP-1 and eIF4E
interaction (C and D), and 4EBP-1 phosphorylation (E). (A, C, and D) The indicated cell lines were transfected with 20 nM of control (Ctrl)
or PP2Ac siRNA for 48 hours. (B) A549 cells were treated with 20 μM CGP57380 for the given times. After the aforementioned treatments,
the whole-cell protein lysates prepared from these cells were subjected to m7GTP pull-down and subsequent detection of the given pro-
teins by Western blot analysis. (E) The given cell lines were transfected with 5 nM of control or PP2Ac siRNA for 48 hours. The cells were
then subjected to preparation of whole-cell protein lysates and subsequent detection of the indicated proteins by Western blot analysis.
LE indicates long exposure.
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assembly.Moreover, we found that inhibition of PP2Awith bothOA and
PP2Ac siRNA increased the levels of Mcl-1 and c-Myc (Figures 5 and
6), two proteins known to be regulated by the cap-dependent
mechanism [9,29]. Importantly, the elevation of both Mcl-1 and
c-Myc is partially mediated by increased eIF4E phosphorylation be-
cause the presence of CGP57380 partially inhibited the elevation of both
Mcl-1 and c-Myc induced by PP2A inhibition (Figures 5 and 6). Col-
lectively, it is reasonable to conclude that PP2A negatively regulates
eIF4F assembly and cap-dependent translation through inhibition of
eIF4E phosphorylation.
4EBP-1 is a key protein that binds to eIF4E and restricts its avail-
ability to form eIF4F. On phosphorylation, 4EBP-1 dissociates from
eIF4E, allowing eIF4E to bind to the mRNA cap structure of a given
gene and to recruit eIF4G [28]. Thus, it is possible that inhibition of
PP2A also increases 4EBP-1 phosphorylation, leading to increased eIF4F
assembly. In our study, we found that inhibition of PP2A with PP2Ac
siRNA did not increase 4EBP-1 phosphorylation (Figure 4E). Likewise,
enforced activation of PP2A by overexpression of ectopic PP2Ac failed
to decrease 4EBP-1 phosphorylation (Figure 1D). These data together
suggest that PP2A does not regulate 4EBP-1 phosphorylation. Accord-
ingly, we think that PP2A inhibition–mediated increase in eIF4F assem-
bly is unlikely due to the alteration of 4EBP-1 phosphorylation.
Withm7GTP pull-down assay, we observed a reduced level of 4EBP-1
bound to eIF4E in the cells transfected with PP2Ac siRNA and an in-
creased amount of 4EBP1 associated with eIF4E in the cells treated with
CGP57380 (Figure 4, C andD). These results indicate that eIF4E phos-
phorylation alters its binding to 4EBP-1. Therefore, it is likely that in-
hibition of PP2A causes increased eIF4E phosphorylation, resulting in
the dissociation of eIF4E from 4EBP-1 and in the subsequent increase
in eIF4F assembly.
Although the expressions of Mcl-1 and c-Myc are regulated by a
cap-dependent translation mechanism, their protein levels are also regu-
lated by protein stabilization through PP2A-mediated inhibition of
protein phosphorylation [30,31,34]. Thus, it is generally thought that
PP2A inhibition elevates the levels of Mcl-1 and c-Myc through in-
creasing their stabilities. The current study in fact reveals an additional
mechanism that contributes to PP2A inhibition–induced increase in
Mcl-1, and particularly c-Myc; that is, PP2A inhibition increases eIF4E
phosphorylation and eIF4F assembly, leading to increased protein
translation of Mcl-1 and c-Myc in addition to increasing their protein
stabilization. We need to point out that c-Myc seems more susceptible
than Mcl-1 to this regulation because CGP57380 had a much more
Figure 5. PP2A knockdown (A) and OA treatment (B) increases
Mcl-1 levels, in part through increasing eIF4E phosphorylation
(C). (A) The indicated cell lines were transfected with 20 nM con-
trol (Ctrl) or PP2Ac siRNA for 48 hours. (B) H157 cells were treated
with 100 nM OA for the indicated times. (C) H157 cells were pre-
treated with 40 μM CGP57380 for 2 hours and then cotreated with
100 nM OA for additional 6 hours. After the aforementioned treat-
ments, the cells were harvested for the preparation of whole-cell
protein lysates and subsequent Western blot analysis. Protein lev-
els were quantitated with ImageJ software (National Institutes of
Health, Bethesda, MD). SE indicates short exposure.
Figure 6. OA treatment (A) or PP2A knockdown (B) increases c-Myc
expression, in part through increasing eIF4E phosphorylation (C). (A)
The indicated cell lines were treated with 100 nM OA for the given
times. (B) H157 cells were transfected with 20 nM control (Ctrl) or
PP2Ac siRNA for 48 hours. (C) H157 cells were pretreated with 20
or 30 μMCGP57380 for 30minutes and then cotreated with 100 nM
OA for an additional 6 hours. After the aforementioned treatments,
the cells were harvested for preparation of whole-cell protein lysates
and subsequent Western blot analysis.
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profound effect on blocking OA-induced c-Myc elevation than on
blocking Mcl-1 increase by OA (Figures 5 and 6).
In summary, the current study demonstrates that PP2A negatively
regulates eIF4E phosphorylation and eIF4F assembly through direct
dephosphorylation of both Mnks and eIF4E, partially leading to reduc-
tion of certain oncogenic proteins (e.g., Mcl-1 and c-Myc; Figure 7).
Our findings in this regard increase our understanding of eIF4E phos-
phorylation and its effect on the regulation of cap-dependent transla-
tion initiation. Given that inactivation of PP2A is an essential step for
fully transforming a normal cell into a cancer cell [10], whereas eIF4E
phosphorylation is an essential step for eIF4E’s oncogenic function [9],
our findings may imply that negative regulation of eIF4E phosphory-
lation and eIF4F activity by PP2A is an important mechanism by which
PP2A exerts its tumor-suppressive function. Our findings thus warrant
further investigation in this direction.
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hibits eIF4F assembly. Accordingly, the expression of certain onco-
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